Search results
Pharma Stock Roundup: LLY's Donanemab Gets FDA's CRL, MRNA RSV Jab Study Succeeds
Zacks via Yahoo Finance· 1 year agoFDA gives CRL to Lilly's (LLY) Alzheimer's candidate, donanemab. Moderna's (MRNA) phase III study on...
Verrica (VRCA) Down 64% as Molluscum Drug Gets CRL From FDA
Zacks via Yahoo Finance· 2 years agoVerrica Pharmaceuticals VRCA announced that the FDA has issued a complete response letter (CRL) to...
Pharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRL
Zacks via Yahoo Finance· 1 year agoThis week, Sanofi SNY and partner Regeneron’s REGN blockbuster medicine, Dupixent succeeded in a...
Pharma Stock Roundup: FDA Nod to AZN's Eplontersen, CRL to MRK's Cough Candidate
Zacks via Yahoo Finance· 4 months agoThis week, the FDA approved AstraZeneca AZN and partner Ionis’ IONS Wainua (eplontersen) for...
Charles River's (CRL) New Cloud Platform Offers Real-Time Data
Zacks via Yahoo Finance· 1 year agoCharles River Laboratories International, Inc.CRL recently launched its cloud-based platform Apollo,...
ARS Pharmaceuticals (SPRY) Down on CRL for Nasal Spray
Zacks via Yahoo Finance· 7 months agoShares of ARS Pharmaceuticals, Inc. SPRY plummeted 55.8% on Sep 20 after the company received a...
Here's Why You Should Retain Charles River (CRL) Stock Now
Zacks via Yahoo Finance· 2 months agoCharles River Laboratories International, Inc. CRL is likely to grow in the coming quarters, backed...
Pharma Stock Roundup: J&J to End Hypertension Study & Other Regulatory Updates
Zacks via Yahoo Finance· 7 months agoThis week, J&J JNJ announced its decision to end a late-stage study evaluating its drug Opsumit...
Spectrum's (SPPI) NDA for NSCLC Candidate Gets CRL From FDA
Zacks via Yahoo Finance· 1 year agoSpectrum Pharmaceuticals, Inc. SPPI announced that the company has received a Complete Response...
Biotech Stock Roundup: SAGE, GRTX Plunge on Setback, REGN to Buy DBTX & More News
Zacks via Yahoo Finance· 8 months agoIt was a busy week for the biotech sector, with a focus on earnings and important regulatory and...